Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PXS-5505 in Myelofibrosis
NCT04676529Phase 2Completed
- Sponsor
- Syntara Limited
- Start
- Feb 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of amsulostat in myelofibrosis (MF), sponsored by Syntara Limited. Started Feb 2021; status: completed.
02
Drugs
amsulostat
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT04676529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04676529.